Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 29;12(3):565.
doi: 10.3390/cancers12030565.

Systematic Review of Patient-Reported Outcomes following Surgical Treatment of Lymphedema

Michelle Coriddi  1 , Joseph Dayan  1 , Nikhil Sobti  2 , David Nash  3 , Johanna Goldberg  1 , Anne Klassen  4 , Andrea Pusic  4 , Babak Mehrara  1
Affiliations
Review

Systematic Review of Patient-Reported Outcomes following Surgical Treatment of Lymphedema

Michelle Coriddi et al. Cancers (Basel). .

Abstract

Introduction: Analysis of quality of life (QOL) outcomes is an important aspect of lymphedema treatment since this disease can substantially impact QOL in affected individuals. There are a growing number of studies reporting patient-reported outcomes (PROMs) for patients with lymphedema. The purpose of this study was to conduct a systematic review of outcomes and utilization of PROMs following surgical treatment of lymphedema.

Methods: A literature search of four databases was performed up to and including March, 2019. Studies included reported on QOL outcomes after physiologic procedures, defined as either lymphovenous bypass (LVB) or vascularized lymph node transplant (VLNT), to treat upper and/or lower extremity primary or secondary lymphedema.

Results: In total, 850 studies were screened-of which, 32 studies were included in this review. Lymphovenous bypass was the surgical intervention in 16 studies, VLNT in 11 studies, and both in 5 studies. Of the 32 total studies, 16 used validated survey tools. The most commonly used PROM was the lymph quality of life measure for limb lymphedema (LYMQOL) (12 studies). In the remaining four studies, the upper limb lymphedema 27 scale (ULL27), the short form 36 questionnaire (SF-36), the lymphedema functioning, disability and health questionnaire (Lymph-ICF), and lymphedema life impact scale (LLIS) were each used once. QOL improvement following surgical treatment was noted in all studies.

Conclusions: Physiologic surgical treatment of lymphedema results in improved QOL outcomes in most patients. The use of validated PROM tools is increasing but there is no current consensus on use. Future research to evaluate the psychometric properties of PROMs in lymphedema is needed to guide the development and use of lymphedema-specific tools.

Keywords: lymph node transplant; lymphedema; lymphovenous bypass; patient-reported outcomes; quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) chart.
Figure 2
Figure 2
Publications with ad-hoc versus validated tools over time.
See this image and copyright information in PMC

References

    1. Lawenda B.D.M.T., Johnstone P.A.S. Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment. Cancer J. Clin. 2009;59:8–24. doi: 10.3322/caac.20001. - DOI - PubMed
    1. Ribeiro Pereira A.C.P.K.R., Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up. Breast. 2017;36:67–73. doi: 10.1016/j.breast.2017.09.006. - DOI - PubMed
    1. Cormier J.N.A.R., Mungovan K.S., Xing Y., Ross M.I., Armer J.M. Lymphedema beyond breast cancer. Cancer. 2010;116:5138–5149. doi: 10.1002/cncr.25458. - DOI - PubMed
    1. Todo Y.Y.R., Minobe S., Suzuki Y., Takeshi U., Nakatani M., Aoyagi Y., Ohba Y., Okamoto K., Kato H. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol. Oncol. 2010;119:60–64. doi: 10.1016/j.ygyno.2010.06.018. - DOI - PubMed
    1. Zou L.L.F., Shen P.P., Hu Y., Liu X.Q., Xu Y.Y., Pen Q.L., Wang B., Zhu Y.Q., Tian Y. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: A 2-year follow-up prospective cohort study. Breast Cancer. 2018;5:309–314. doi: 10.1007/s12282-018-0830-3. - DOI - PubMed

LinkOut - more resources